81 related articles for article (PubMed ID: 7485761)
1. [Changes in the contents of phosphoinositides in formed elements of blood and endometrial tissue in patients with hyperplastic processes and cancer of the endometrium].
Damirov MM; Kulakov VI; Sliusar' NN; Bakuleva LP
Akush Ginekol (Mosk); 1995; (4):43-6. PubMed ID: 7485761
[TBL] [Abstract][Full Text] [Related]
2. Total sialic acid content in endometrial cancer tissue in relation to normal and hyperplastic human endometrium.
Paszkowska A; Cybulski M; Semczuk A; Postawski K; Berbe H
Cancer Detect Prev; 2000; 24(5):459-63. PubMed ID: 11129988
[TBL] [Abstract][Full Text] [Related]
3. Leukaemia inhibitory factor (LIF) is immunohistochemically expressed in normal, hyperplastic and malignant endometrial tissue.
Mylonas I; Makovitzky J; Shabani N; Richter DU; Kuhn C; Jeschke U; Briese V; Friese K
Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):101-8. PubMed ID: 15596282
[TBL] [Abstract][Full Text] [Related]
4. PINCH protein expression in normal endometrium, atypical endometrial hyperplasia and endometrioid endometrial carcinoma.
Zhang HZ; Li XH; Zhang X; Zhang ZY; Meng YL; Xu SW; Zheng Y; Zhu ZL; Cui DS; Huang LX; Yan BY; Sun XF
Chemotherapy; 2010; 56(4):291-7. PubMed ID: 20714146
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin D expression in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis.
Mylonas I; Makovitzky J; Richter DU; Jeschke U; Briese V; Friese K
Acta Histochem; 2003; 105(3):245-52. PubMed ID: 13677618
[TBL] [Abstract][Full Text] [Related]
6. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
Afify AM; Craig S; Paulino AF; Stern R
Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone-related peptide (PTH-rp) in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis.
Mylonas I; Makovitzky J; Shabani N; Richter DU; Jeschke U; Briese V; Friese K
Anticancer Res; 2005; 25(3A):1633-8. PubMed ID: 16033073
[TBL] [Abstract][Full Text] [Related]
8. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer.
Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N
Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630
[TBL] [Abstract][Full Text] [Related]
9. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
[TBL] [Abstract][Full Text] [Related]
10. Inhibin (10.7 kD prostatic peptide) in normal, hyperplastic, and malignant human endometria: an immunohistochemical study.
Teni TR; Sampat MB; Sheth NA
J Pathol; 1992 Sep; 168(1):35-40. PubMed ID: 1453268
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.
Ozuysal S; Oztürk H; Bilgin T; Filiz G
Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of CD44s and CD44v6 in endometriosis and adenomyosis : comparison with normal, hyperplastic, and malignant endometrium.
Lin Z; Cho S; Jeong H; Kim H; Kim I
J Korean Med Sci; 2001 Jun; 16(3):317-22. PubMed ID: 11410693
[TBL] [Abstract][Full Text] [Related]
13. Production of activin A in hyperplasia and adenocarcinoma of the human endometrium.
Otani T; Minami S; Yamoto M; Umesaki N
Gynecol Oncol; 2001 Oct; 83(1):31-8. PubMed ID: 11585411
[TBL] [Abstract][Full Text] [Related]
14. Effects of hormone therapy on the endometrium.
Deligdisch L
Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin and alpha-catenin expression in normal, hyperplastic and neoplastic endometrium.
Carico E; Atlante M; Giarnieri E; Raffa S; Bucci B; Giovagnoli MR; Vecchione A
Anticancer Res; 2010 Dec; 30(12):4993-7. PubMed ID: 21187480
[TBL] [Abstract][Full Text] [Related]
16. [Extracellular signal-regulated protein kinase activation in endometrium with polycystic ovary syndrome and its significance].
Song XR; Zhang HY; Zhang YF; Han YK; Li KJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):767-71. PubMed ID: 21176559
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
[TBL] [Abstract][Full Text] [Related]
18. Expression of HER-2/neu oncogene in normal, hyperplastic, and malignant endometrium.
Rasty G; Murray R; Lu L; Kubilis P; Benrubi G; Masood S
Ann Clin Lab Sci; 1998; 28(3):138-43. PubMed ID: 9646853
[TBL] [Abstract][Full Text] [Related]
19. Expression of cold-inducible RNA-binding protein in the normal endometrium, endometrial hyperplasia, and endometrial carcinoma.
Hamid AA; Mandai M; Fujita J; Nanbu K; Kariya M; Kusakari T; Fukuhara K; Fujii S
Int J Gynecol Pathol; 2003 Jul; 22(3):240-7. PubMed ID: 12819390
[TBL] [Abstract][Full Text] [Related]
20. The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer.
Nakamura K; Hongo A; Kodama J; Hiramatsu Y
Int J Cancer; 2011 Jun; 128(11):2613-24. PubMed ID: 20715109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]